Serum hematopoietic growth factors as diagnostic and prognostic markers of acute renal allograft rejection: A potential role for serum stem cell factor

Cytokine

Volumn 56, Issue 3, 2011, Pages 779-785

  Xu, Xiaoguang ^a   Huang, Haiyan ^a   Cai, Ming ^a   Qian, Yeyong ^a   Han, Yong ^a   Xiao, Li ^a   Zhou, Wenqiang ^a   Wang, Xinying ^a   Shi, Bingyi ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

Biomarker; Cytokine; Diagnosis; Rejection

Indexed keywords

BIOLOGICAL MARKER; COLONY STIMULATING FACTOR 1; CYTOKINE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 7; STEM CELL FACTOR; THROMBOPOIETIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOCOMPATIBILITY; HUMAN; KIDNEY ALLOGRAFT REJECTION; LYMPHOCYTE FUNCTION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MODELS, BIOLOGICAL; PROGNOSIS; ROC CURVE; STEM CELL FACTOR;

EID: 81455154335     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.09.011     Document Type: Article

References (65)

1. Mas 1.V.R., Mueller T.F., Archer K.J., Maluf D.G. Identifying biomarkers as diagnostic tools in kidney transplantation. Expert Rev Mol Diagn 2011, 11(2):183-196.
2. Halawa A. The early diagnosis of acute renal graft dysfunction: a challenge we face. the role of novel biomarkers. Ann Transplant 2011, 16(1):90-98.
3. Naesens M., Sarwal M. Molecular diagnostics in transplantation. Nat Rev Nephrol 2010, 6(10):614-628.
4. Bestard O., Cruzado J.M., la Franquesa M., Grinyó J.M. Biomarkers in renal transplantation. Curr Opin Organ Transplant 2010, 15(4):467-473.
5. Kitchens W.H., Uehara S., Chase C.M., Colvin R.B., Russell P.S., Madsen J.C. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006, 81:811-817.
6. Hoffmann S.C., Hale D.A., Kleiner D.E., Mannon R.B., Kampen R.L., Jacobson L.M., et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005, 5:573-581.
7. Segerer S., Cui Y., Eitner F., Goodpaster T., Hudkins K.L., Mack M., et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001, 37:518-531.
8. Weisbart R.H., Golde D.W., Clark S.C., Wong G.G., Gasson J.C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 1985, 314(6009):361-363.
9. Vadas M.A., Nicola N.A., Metcalf D. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Immunol 1983, 130(2):795-799.
10. Grabstein K.H., Urdal D.L., Tushinski R.J., Mochizuki D.Y., Price V.L., Cantrell M.A., et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986, 232(4749):506-508.
11. M. Khajah, B. Millen, D.C. Cara, C. Waterhouse, D.M. McCafferty, Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo, J Leuk Biol Mar 10, (2011) [Epub ahead of print].
12. Lopez A.F., Nicola N.A., Burgess A.W., Metcalf D., Battye F.L., Sewell W.A., et al. Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol 1983, 131(6):2983-2988.
13. Hamilton J.A., Stanley E.R., Burgess A.W., Shadduck R.K. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 1980, 103(3):435-445.
14. Ray P., Krishnamoorthy N., Ray A. Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation. Cell Cycle 2008, 7(18):2826-2832.
15. Dolgachev V.A., Ullenbruch M.R., Lukacs N.W., Phan S.H. Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. Am J Pathol 2009, 174(2):390-400.
16. Da Silva C.A., Adda M., Stern M., de Blay F., Frossard N., Israel-Biet D. Marked stem cell factor expression in the airways of lung transplant recipients. Respir Res 2006, 7:90.
17. Baccarani U., De Stasio G., Adani G.L., Donini A., Sainz-Barriga M., Lorenzin D., et al. Implication of stem cell factor in human liver regeneration after transplantation and resection. Growth Factors 2006, 24(2):107-110.
18. G Oliveira J., Xavier P., Neto S., Mendes A.A., Guerra L.E. Monocytes-macrophages and cytokines/chemokines in fine-needle aspiration biopsy cultures: enhanced interleukin-1 receptor antagonist synthesis in rejection-free kidney transplant patients. Transplantation 1997, 63(12):1751-1756.
19. Jose M.D., Le Meur Y., Atkins R.C., Chadban S.J. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant 2003, 3(3):294-300.
20. Le Meur Y., Leprivey-Lorgeot V., Mons S., José M., Dantal J., Lemauff B., et al. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection. Nephrol Dial Transplant 2004, 19(7):1862-1865.
21. Le Meur Y., Jose M.D., Mu W., Atkins R.C., Chadban S.J. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 2002, 73(8):1318-1324.
22. Alachkar N., Ugarte R., Huang E., Womer K.L., Montgomery R., Kraus E., et al. Stem cell factor, interleukin-16, and interleukin-2 receptor alpha are predictive biomarkers for delayed and slow graft function. Transplant Proc 2010, 42(9):3399-3405.
23. Budde K., Waiser J., Neumayer H.H. The diagnostic value of GM-CSF and IL-6 determinations in patients after renal transplantation. Transpl Int 1994, 7(Suppl. 1):S97-S101.
24. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007, 7(3):518-526.
25. Isbel N.M., Hill P.A., Foti R., Mu W., Hurst L.A., Stambe C., et al. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int 2001, 60(2):614-625.
26. Newman S.L., Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect Immun 1992, 60(11):4593-4597.
27. + dendritic cells. Proc Natl Acad Sci USA 1996, 93:2588-2592.
28. + monocyte-derived dendritic cells: insights into phenotype and function. Exp Hematol 1998, 26:1255-1264.
29. Zheng Z., Takahashi M., Narita M., Toba K., Liu A., Furukawa T., et al. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J Hematother Stem Cell Res 2000, 9:453-464.
30. Xu H., Dhanireddy K.K., Kirk A.D. Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in the initiation of alloimmunity. J Immunol 2006, 176:750-761.
31. Nickerson P., Steurer W., Steiger J., Zheng X., Steele A.W., Strom T.B. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994, 6:757.
32. Fitch F.W., McKisic M.D., Lancki D.W., Gajewski T.F. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993, 11:29.
33. Oliveira J.G., Xavier P., Neto S., Mendes A.A., Guerra L.E. Monocytes-macrophages and cytokines/chemokines in fine-needle aspiration biopsy cultures: enhanced interleukin-1 receptor antagonist synthesis in rejection-free kidney transplant patients. Transplantation 1997, 63(12):1751-1756.
34. Nathan C.F. Secretory products of macrophages. J Clin Invest 1987, 79:319-326.
35. Baricos W.H., Shah S.V. Proteolytic enzymes as mediators of glomerular injury. Kidney Int 1991, 40:161-173.
36. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int 1994, 45:945-952.
37. Tinkam K.J., Djurdjev O., Magil A.B. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005, 68:1866-1874.
38. Imasawa T., Utsunomiya Y. Stem cells in renal biology: bone marrow transplantation for the treatment of IgA nephropathy. Exp Nephrol 2002, 10(1):51-58.
39. Forbes S.J., Poulsom R., Wright N.A. Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 2002, 9(10):625-630.
40. Yeagy BA, Cherqui S. Kidney repair and stem cells: a complex and controversial process, Pediatr Nephrol Feb 19 (2011) [Epub ahead of print].
41. Fangmann J., Kathrin Al-Ali H., Sack U., Kamprad M., Tautenhahn H.M., Faber S. Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant 2011, 11(1):156-162.
42. Duarte R.F., Franf D.A. The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevance. Leuk Lymphoma 2002, 43(6):1179-1187.
43. Urdziková L, Likavčanová-MaŠínová K, Vaněček V, RůŽička J, Sedý J, Syková E, Jendelová P. Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat, Cytotherapy. May 4 (2011) [Epub ahead of print].
44. Rabbany S.Y., Heissig B., Hattori K., Rafii S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 2003, 9(3):109-117.
45. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98:10344-10349.
46. Das A.V., James J., Zhao X., Rahnenfuhrer J., Ahmad I. Identification of c-kit receptor as a regulator of adult neural stem cells in the mammalian eye: interactions with Notch signaling. Dev Biol 2004, 273(1):87-105.
47. Peters K., Panienka R., Li J., Kloppel G., Wang R. Expression of stem cell markers and transcription factors during the remodeling of the rat pancreas after duct ligation. Virchows Arch 2005, 446(1):56-63.
48. Sun L., Lee J., Fine H.A. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 2004, 113(9):1364-1374.
49. Baumann U., Crosby H.A., Ramani P., Kelly D.A., Strain A.J. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell?. Hepatology 1999, 30(1):112-117.
50. Hollenbeck S.T., Sakakibara K., Faries P.L., Workhu B., Liu B., Kent K.C. Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res 2004, 120(2):288-294.
51. Kanellakis P., Slater N.J., Du X.J., Bobik A., Curtis D.J. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovasc Res 2006, 70(1):117-125.
52. Ripa R.S., Jørgensen E., Wang Y., Thune J.J., Nilsson J.C., Søndergaard L., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006, 113(16):1983-1992.
53. Galli S.J., Zsebo K.M., Geissler E.N. The kit ligand, stem cell factor. Adv Immunol 1994, 55:1-96.
54. Flanagan J.G., Chan D.C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991, 64(5):1025-1035.
55. Toksoz D., Zsebo K.M., Smith K.A., Hu S., Brankow D., Suggs S.V., et al. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992, 89(16):7350-7354.
56. Huang E.J., Nocka K.H., Buck J., Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 1992, 3(3):349-362.
57. Majumdar M.K., Feng L., Medlock E., Toksoz D., Williams D.A. Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem 1994, 269(2):1237-1242.
58. Longley B.J., Tyrrell L., Ma Y., Williams D.A., Halaban R., Langley K., et al. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 1997, 94(17):9017-9021.
59. Colvin R.B., Dvorak HF H.F. Letter: basophils and mast cells in renal allograft rejection. Lancet 1974, 1(7850):212-214.
60. Lajoie G., Nadasdy T., Laszik Z., Blick K.E., Silva F.G. Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 1996, 9(12):1118-1125.
61. Mao Y.Y., Yang H., Wang M., Peng W., He Q., Shou Z.F., et al. Feasibility of diagnosing renal allograft dysfunction by oligonucleotide array: gene expression profile correlates with histopathology. Transpl Immunol 2011, 24(3):172-180.
62. Reber L., Da Silva C.A., Frossard N. Stem cell factor and its receptor c-kit as targets for inflammatory diseases. Eur J Pharmacol 2006, 533(1-3):327-340.
63. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786.
64. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142.
65. Hershko A.Y., Rivera J. Mast cell and T cell communication; amplification and control of adaptive immunity. Immunol Lett 2010, 128(2):98-104.